QGEN (Qiagen NV) Total Debt per Share: $7.91 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

QGEN Qiagen NV QGEN
76 GF Score
Price $42.65
GF Value $49.74
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Qiagen NV Total Debt per Share?

Qiagen NV QGEN -2.74% 76 Total Debt per Share is $7.91 as of Jun. 2026. GuruFocus rates QGEN with a GF Score™ of 76/100 and a GF Value™ of $49.74 (Modestly Undervalued). The stock has 3 warning signs investors should review.

$7.91 (As of Jun. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Qiagen NV's Total Debt Per Share for the quarter that ended in Jun. 2026 was $7.91.


Qiagen NV Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Qiagen NV's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qiagen NV Total Debt per Share Chart

Qiagen NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.65 9.23 7.49 7.37 8.80

Qiagen NV Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.01 10.33 8.80 7.98 7.91
QGEN
76GF Score
Qiagen NV QGEN
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qiagen NV Total Debt per Share Calculation

Qiagen NV's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Qiagen NV's Total Debt Per Share for the quarter that ended in Jun. 2026 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of $7.91 mean?
Qiagen NV (QGEN) has a Total Debt per Share of $7.91 as of Jun. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Qiagen NV and its competitors.
Is Qiagen NV's Total Debt per Share too high?
Qiagen NV's current Total Debt per Share is $7.91. Overall, Qiagen NV has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qiagen NV's Total Debt per Share compare to CRL and BLLN?
Qiagen NV's Total Debt per Share of $7.91 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Medical Diagnostics & Research company?
A good Total Debt per Share depends on the Medical Diagnostics & Research industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Qiagen NV and its competitors. Qiagen NV's current Total Debt per Share is $7.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qiagen NV stock overvalued right now?
Based on GuruFocus' analysis, Qiagen NV (QGEN) is currently considered Modestly Undervalued. The stock's GF Value™ is $49.74, compared to a current price of $42.65 — trading 14.3% below its estimated fair value. The current Total Debt per Share is $7.91. Qiagen NV's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Qiagen NV (QGEN), the current Total Debt per Share is $7.91 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Qiagen NV (QGEN) Overvalued in 2026?

Based on GuruFocus' analysis, Qiagen NV stock appears to be undervalued. The current stock price of $42.65 is trading 14.3% below its estimated GF Value™ of $49.74. GuruFocus considers Qiagen NV to be Modestly Undervalued.

Key valuation signals for QGEN:

  • Total Debt per Share: $7.91
  • GF Value™: $49.74 vs. price of $42.65 (14.3% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the QGEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Qiagen NV Business Description

Address Hulsterweg 82, Venlo, LI, NLD, 5912 PL
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
76GF Score

Get the complete analysis for QGEN

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$42.65
Price
$49.74
GF Value